On the Record · Phibro Animal Health
Phibro Animal Health acquisitions, on the record
The businesses Phibro Animal Health bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
Zoetis Inc.'s medicated feed additive (MFA) product portfolio, certain water-soluble products and related assetsWord for word“In April 2024, we entered into a Purchase and Sale Agreement (the “Purchase Agreement”) with Zoetis Inc. (“Zoetis”) to acquire Zoetis’s medicated feed additive (MFA) product portfolio, certain water- soluble products and related assets (the “Proposed Acquisition”).” 10-K for 2024 | agreed acquisition | April 2024 | — |
a businessWord for word“We acquired a business for $3.3 million, net of cash acquired.” 10-K for 2024 | acquisition | — | $3.3 million, net of cash acquired |
Zoetis Inc.'s medicated feed additive (MFA) portfolio, certain water-soluble products and related assetsWord for word“In April 2024, the Company entered into a Purchase and Sale Agreement (the “Purchase Agreement”) with Zoetis Inc., a Delaware corporation (“Zoetis”) to acquire Zoetis’s medicated feed additive (“MFA”) portfolio, certain water-soluble products and related assets (the “Acquisition”).” 10-K for 2025 | agreed acquisition | In April 2024 | — |
Zoetis Inc.'s medicated feed additive portfolio, certain water-soluble products and related assetsWord for word“On October 31, 2024, the Company completed the Acquisition at a purchase price of approximately $297.5 million ($286.5 million, as adjusted, net of cash acquired), subject to certain further adjustments set forth in the Purchase Agreement.” 10-K for 2026 | acquisition | On October 31, 2024 | approximately $297.5 million |
| Fiscal year ended | Cash paid for acquisitions (net of cash acquired) | Goodwill from acquisitions |
|---|---|---|
| 2016-06-30 | — | $8.5 million |
| 2017-06-30 | — | $0 |
| 2018-06-30 | — | $5.6 million |
| 2019-06-30 | — | $0 |
| 2020-06-30 | — | $25.3 million |
| 2021-06-30 | — | $0 |
| 2022-06-30 | $13.5 million | $561,000 |
| 2024-06-30 | $3.3 million | $1.4 million |
| 2025-06-30 | $286.5 million | $4.9 million |
Deal filings since 2016
- 2026-04-30 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-10-31 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2024-07-09 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-04-29 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2023-06-16 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2021-04-22 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2019-08-01 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2018-07-31 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2018-05-07 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-06-29 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-12-23 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-01-25 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2016-01-19 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-01-12 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
Read from Phibro Animal Health’s annual reports (10-K for 2026, 10-K for 2025, 10-K for 2024) and the financial data it files with the SEC, as of 2026-08-26. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.